XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flow from operating activities    
Net loss $ (6,210) $ (6,674)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 522 416
Amortization of technology license 0 121
Amortization of right of use assets 75 0
Depreciation 116 198
(Increase) decrease in operating assets    
Prepaid drug product for testing (433) 860
Other current assets 64 72
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses (187) 166
Lease liabilities (63) 0
Net cash used in operating activities (6,116) (4,841)
Cash flow from investing activities    
Purchases of furniture, fixtures & equipment 0 (17)
Net cash used in investing activities 0 (17)
Cash flow from financing activities    
Net proceeds from sale of common stock 19,411 1,179
Net proceeds from exercise of warrants 1,083 0
Net cash provided by financing activities 20,494 1,179
Net increase (decrease) in cash 14,378 (3,679)
Cash, beginning of period 1,004 5,965
Cash, end of period 15,382 $ 2,286
Non-cash investing activities    
Non-cash leasehold improvements $ (31)